10.28.26 -- The U.S. Clinical Trial Recruiting Pipeline – September 2026

By collapsing the gaps between manufacturing and clinical trials and integrating these functions into a unified system, teams can adjust formulations in real-time and accelerate timelines.

As early phase clinical trials become more sophisticated, sponsors are now leveraging flexible IRT solutions to replace error-prone manual processes and gain greater control and efficiency.

A look at implementing randomization mid-trial by reconstructing subject and inventory records without disrupting sites or compromising data integrity.

Consider this streamlined, end-to-end solution that helped safeguard study timelines and ensured that patients with urgent medical needs could receive treatment without delay.

Adaptive trial designs and an adaptive mindset enable non-small cell lung cancer (NSCLC) sponsors to optimize dose, respond to evolving expectations, and accelerate early‑phase development.

Commercial growth brings new PV challenges. Gain practical insights on operating models, technology, governance, and leadership for long-term success.

Discover how these devices offer solutions to the challenges of precise dosing, patient compliance, retention, and safety, uplifting the overall trial experience and providing real world insights.

When trial data fall short, real risk signals surface in inquiries, complaints, and reports. Learn how coordinated, cross-functional practices help catch risk earlier.

Mechanism-specific autoimmune treatments demand deeper biological insight. Discover how an integrated trial strategy improves signal detection.

Decentralized and hybrid trial models are reshaping CNS research. Learn how to match virtual tools to your study design, endpoints, and patient population for better outcomes.

Learn how remote lifestyle coaching can combat high dropout rates in metabolic research by offering the support participants need to maintain adherence and ensure data integrity.